Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.

Patient-derived tumor organoids are the latest tool in predictive translational research. Current organoid-based studies in precision medicine have shown their great potential for predicting the clinical response of patients to CRC therapy. Larger-scale, prospective data are required to fully support this exciting avenue in cancer care.